The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Increase In Market Value Is Predicted For The Infectious Disease Diagnostics Testing Market During The 2026–2030 Period?
The infectious disease diagnostics testing market size has experienced swift expansion in recent years. It is projected to expand from $42.24 billion in 2025 to $46.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.0%. This historical expansion is attributable to several factors, including the escalating prevalence of infectious diseases, a rising incidence of respiratory infections, the expansion of diagnostic laboratory infrastructure, increasing awareness of early disease diagnosis, and a heightened government focus on disease control.
The infectious disease diagnostics testing market size is projected to undergo significant expansion in the coming years. By 2030, its value is expected to reach $65.49 billion, expanding at a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period is primarily driven by the increasing threat of global pandemics, a heightened need for rapid diagnostic solutions, rising investments within healthcare diagnostics, the expansion of disease surveillance programs, and the increasing burden of tropical and viral diseases. Furthermore, prominent trends anticipated for this period include a surging demand for swift and early detection of infectious diseases, the broader adoption of point-of-care infectious disease tests, a growing reliance on molecular diagnostics for pathogen identification, an expansion of diagnostic testing for emerging and re-emerging infections, and an intensified focus on extensive disease screening and surveillance.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp
What Core Drivers Are Transforming The Infectious Disease Diagnostics Testing Market?
The expected growth of the infectious disease diagnostic testing market is significantly influenced by a rise in respiratory infections, which impact parts of the respiratory system such as the nose, throat, airways, and lungs. These increasing infections are attributable to viral and bacterial transmission through close contact, poor hygiene, crowded living conditions, and seasonal weather changes. Infectious disease diagnostic testing plays a vital role in the diagnosis and treatment of these infections by accurately identifying pathogens like bacteria and viruses in patient samples. For example, in February 2024, the Canadian Institute for Health Information, a Canada-based non-profit organization, reported a 32% increase in hospitalizations for acute upper respiratory infections, climbing from 2,114 in 2022 to 2,797 cases in 2023. This upward trend in respiratory infections is thus propelling the infectious disease diagnostic testing market.
What Are The Core Segment Classifications In The Infectious Disease Diagnostics Testing Market?
The infectious disease diagnostics testing market covered in this report is segmented –
1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics
Subsegments:
1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs)
2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR
Which Trends Are Expected To Shape The Infectious Disease Diagnostics Testing Market?
Leading companies in the infectious disease diagnostic testing market are advancing sophisticated technologies for the rapid and reliable identification of critical infections. Infectious disease diagnostics involves pinpointing pathogens, such as bacteria, viruses, or parasites, to guide diagnosis and subsequent treatment. For example, in January 2025, QIAGEN, a biotechnology company based in Germany, launched new QIAstat-Dx syndromic testing panels in India. These include the Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel, introduced alongside the previously authorized Respiratory SARS-CoV-2 Panel, all of which received approval from India’s Central Drugs Standard Control Organization (CDSCO). The QIAstat-Dx system utilizes multiplex real-time PCR with single-use cartridges to detect multiple pathogens concurrently, providing results in about an hour for gastrointestinal infections and 80 minutes for central nervous system infections. These panels enhance the speed and accuracy of diagnosis compared to traditional methods, facilitating timely treatment, improving patient outcomes, and reducing the burden on healthcare systems. Additionally, the system offers configurable setups and cloud connectivity for remote monitoring and efficient data management.
Which Organizations Are Operating Within The Infectious Disease Diagnostics Testing Market?
Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC
Access The Complete Infectious Disease Diagnostics Testing Market Report:
What Is The Largest Regional Market In The Infectious Disease Diagnostics Testing Market?
North America was the largest region in the infectious disease diagnostics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Infectious Disease Diagnostics Testing Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Infectious Disease Diagnostics Testing Market 2026, By The Business Research Company
Disposable Incontinence Products Market Report 2026
Urinary Incontinence Market Report 2026
https://www.thebusinessresearchcompany.com/report/urinary-incontinence-global-market-report
Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model